Insights

Gathering insights about Molo…

Similar companies to Molo

Molo Tech Stack

Molo uses 8 technology products and services including Bing Ads, Apple iCloud Mail, Google Fonts API, and more. Explore Molo's tech stack below.

Bing Ads
Advertising Networks
Apple iCloud Mail
Email
Google Fonts API
Font Scripts
Modernizr
Javascript Libraries
Polyfill
Javascript Libraries
Lodash
Javascript Libraries
Google Tag Manager
Tag Management
Microsoft IIS
Web Servers

Media & News

Homology Medicines Declares Distribution to Common Stockholders
BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of the right to receive one contingent value right (CVR) for each outstanding share of Homology common stock held by such stockholder as of such record date. The payment date for such distribution is expected to be March 27, 2024 (three business days after the expected closing of the merger on March 22, 2024). Each CVR represents the non-transferable contractual right to receive certain contingent payments upon the occurrence of certain events within agreed time periods as provided in the merger agreement and agreement governing the CVRs.
Mar 18, 2024 | www.globenewswire.com
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology Medicines, Inc. (NasdaqGS: FIXX) with Q32 Bio Inc. Under the terms of the proposed transaction, Homology shareholders will end up owning approximately 25% of the combined company, subject to possible adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequa.
Feb 27, 2024 | www.businesswire.com
HOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
NEW ORLEANS , Jan. 26, 2024 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Jan 26, 2024 | www.prnewswire.com
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement
Jan 03, 2024 | www.globenewswire.com
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology Medicines, Inc. (NasdaqGS: FIXX) with Q32 Bio Inc. Under the terms of the proposed transaction, Homology shareholders will end up owning approximately 25% of the combined company, subject to possible adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequa.
Nov 17, 2023 | www.businesswire.com
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Homology Medicines, Inc. (NASDAQ: FIXX) and Q32 Bio Inc. is fair to Homology shareholders. Upon completion of the proposed transaction, Homology shareholders are expected to own approximately 25% of the combined company. Halper Sadeh encourages Homology shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763.
Nov 16, 2023 | www.businesswire.com
Q32 Bio and Homology Medicines Announce Merger Agreement
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart (ADX-914) in Phase 2 for the treatment of atopic dermatitis (AD) and alopecia areata (AA), and ADX-097 entering Phase 2 for the treatment of complement disorders-- --Q32 Bio has re-acquired worldwide development and commercial rights to bempikibart, an anti-IL-7Rα antibody inhibiting IL-7 and TSLP-mediated signaling, and remains on-track to report multiple topline Phase 2 results in 2H'24 -- --Concurrent $42 million private placement investment with new and existing investors supports clinical development through multiple milestones, including key Phase 2 readouts for bempikibart, initial ADX-097 proof-of-concept data by year-end 2024 and ADX-097 topline results in 2H'25 -- --Combined company's cash balance expected to be approximately $ 115 million at close, providing cash runway to mid-2026-- WALTHAM, Mass. and BEDFORD, Mass.
Nov 16, 2023 | www.prnewswire.com

Molo's Email Address Formats

Molo uses at least 1 format(s):

Molo Email Formats	Example	Percentage
FL@molo.com	JD@molo.com	67%
FirstLast@molo.com	JohnDoe@molo.com	16%
LF@molo.com	DJ@molo.com	11%
FirLast@molo.com	JohDoe@molo.com	6%

Frequently Asked Questions

Where is Molo's headquarters located?

Molo's main headquarters is located at 49b Rentemestervej København nv, Hovedstaden 2400 Denmark. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Molo's stock symbol?

Molo is a publicly traded company; the company's stock symbol is FIXX.

What is Molo's official website and social media links?

Molo's official website is molo.com and has social profiles on LinkedIn.

What is Molo's SIC code NAICS code?

Molo's SIC code is 2323 - Men's and Boys' Neckwear NAICS code is 448 - Clothing and Clothing Accessories Stores.

How many employees does Molo have currently?

As of March 2026, Molo has approximately 164 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Cfo: F. S.Head Of Marketing: N. A. S.Head Of Sales, Nordic+, Eastern Europe: M. M.. Explore Molo's employee directory with LeadIQ.

What industry does Molo belong to?

Molo operates in the Retail Apparel and Fashion industry.

What technology does Molo use?

Molo's tech stack includes Bing AdsApple iCloud MailGoogle Fonts APIModernizrPolyfillLodashGoogle Tag ManagerMicrosoft IIS.

What is Molo's email format?

Molo's email format typically follows the pattern of FL@molo.com. Find more Molo email formats with LeadIQ.

When was Molo founded?

Molo was founded in 2003.

Molo

Q: What is Molo's official website and social media links?

Molo's official website is molo.com. Molo has social profiles on LinkedIn.

Q: How many employees does Molo have currently?

Molo has approximately 164 employees.

Q: What technology does Molo use?

Molo's tech stack includes HSTS, Hotjar, Modernizr, Swiper, Apple iCloud Mail.

Retail Apparel and FashionHovedstaden, Denmark51-200 Employees

Welcome to Molo's Linkedin page. Here you can get the most important news about Molo and the world that surrounds and inspires us. 

Our philosophy is simple; children’s design on children’s terms!

We believe that children’s clothing has to be designed on children’s terms so they can express their creativity and personality through their clothes. We believe in clothing designed for real life, not just special occasions. Children need clothing that allows them to move freely, express themselves openly and fearlessly explore a world of delightful possibilities- not clothing that restricts their movements.

CVR-nr: 27229166